首頁 > 市場調查報告書 > 醫療設備

體外診斷感染疾病

市場調查報告書

商品編碼

1777161

2025-2029年全球性行為感染傳染病（STD）治療市場

Global Sexually Transmitted Diseases (STD) Treatment Market 2025-2029

出版日期: 2025年07月17日 | 出版商:

TechNavio | 英文 220 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

預計2024年至2029年，性行為感染傳染病 (STD) 治療市場規模將達242.052億美元，預測期內複合年成長率為7%。本報告對性行為感染傳染病 (STD) 治療市場進行了全面分析，包括市場規模和預測、趨勢、成長動力、挑戰以及涵蓋約25家供應商的分析。

該報告提供了當前市場狀況、最新趨勢和促進因素以及整體市場環境的最新分析。市場受到性傳染病盛行率不斷上升、有利的報銷政策和性傳染病治療覆蓋率的存在以及世界各國政府日益增多的舉措的推動。

市場覆蓋
基準年	2025
年底	2029
預測期	2025-2029
成長動力	加速度
同比	6.5%
複合年成長率	7%
增量金額	242.052億美元

這項研究客觀地結合了一手和二手訊息，並納入了行業主要參與者的意見。報告包含對主要企業的分析，以及全面的市場規模數據、區域細分和供應商格局。報告還提供歷史數據和預測數據。

該研究指出，性傳染病 (STD) 快速診斷技術的進步是推動未來幾年性行為感染傳染病 (STD) 治療市場成長的主要因素之一，隨著各種組織擴大參與提高人們對性傳染病的認知以及性傳染病治療 (EPT) 的日益普及，市場需求將大幅成長。

區域細分
區域比較
北美：市場規模與預測，2024-2029
歐洲：市場規模及預測，2024-2029
亞洲：市場規模及預測，2024-2029
世界其他地區：市場規模及預測（2024-2029）
美國：市場規模與預測，2024-2029
中國：市場規模及預測，2024-2029
德國：市場規模及預測，2024-2029年
加拿大：市場規模與預測，2024-2029
英國：市場規模與預測，2024-2029
法國：市場規模及預測（2024-2029）
印度：市場規模及預測，2024-2029
義大利：市場規模及預測（2024-2029）
日本：市場規模及預測，2024-2029年
西班牙：市場規模及預測（2024-2029）
各地區市場機會

第13章促進因素、挑戰、機會與限制因素

市場促進因素
市場挑戰
促進因素和挑戰的影響
市場機會與限制

第14章競爭格局

概述
競爭格局
令人困惑的情況
產業風險

第15章競爭分析

公司簡介
企業排名指數
公司市場定位
Aurobindo Pharma Ltd.
Becton Dickinson and Co.
Cepheid Inc.
DiaSorin SpA
F. Hoffmann La Roche Ltd.
Gilead Sciences Inc.
GlaxoSmithKline Plc
Hologic Inc.
Inovio Pharmaceuticals Inc.
Johnson and Johnson Services Inc.
Lupin Ltd.
Merck and Co. Inc.
Mission Pharmacal Co.
Mylan
Thermo Fisher Scientific Inc.

第16章附錄

簡介目錄圖表

Product Code: IRTNTR74264

The sexually transmitted diseases (STD) treatment market is forecasted to grow by USD 24,205.2 mn during 2024-2029, accelerating at a CAGR of 7% during the forecast period. The report on the sexually transmitted diseases (STD) treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of stds, presence of favorable reimbursement policies treatment coverage for stds, and increased initiatives by governments worldwide.

Market Scope
Base Year	2025
End Year	2029
Series Year	2025-2029
Growth Momentum	Accelerate
YOY 2025	6.5%
CAGR	7%
Incremental Value	$24,205.2 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's sexually transmitted diseases (STD) treatment market is segmented as below:

By Type

Viral infections
Bacterial infections
Others

By Route Of Administration

Oral
Topical
Injectable

By End-user

Hospital and clinics
Diagnostic centers
Individuals

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the advances in rapid diagnosis of stds as one of the prime reasons driving the sexually transmitted diseases (STD) treatment market growth during the next few years. Also, increasing involvement of various organizations to create awareness about stds and growing adoption of ept will lead to sizable demand in the market.

The report on the sexually transmitted diseases (STD) treatment market covers the following areas:

Sexually Transmitted Diseases (STD) Treatment Market sizing
Sexually Transmitted Diseases (STD) Treatment Market forecast
Sexually Transmitted Diseases (STD) Treatment Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading sexually transmitted diseases (STD) treatment market vendors that include Aurobindo Pharma Ltd., Becton Dickinson and Co., Cepheid Inc., DiaSorin SpA, F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Hologic Inc., Inovio Pharmaceuticals Inc., Johnson and Johnson Services Inc., Lupin Ltd., Merck and Co. Inc., Mission Pharmacal Co., Mylan, and Thermo Fisher Scientific Inc.. Also, the sexually transmitted diseases (STD) treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global Sexually Transmitted Diseases (STD) Treatment Market 2019 - 2023
- Historic Market Size - Data Table on Global Sexually Transmitted Diseases (STD) Treatment Market 2019 - 2023 ($ million)
5.2 Type segment analysis 2019 - 2023
- Historic Market Size - Type Segment 2019 - 2023 ($ million)
5.3 Route of Administration segment analysis 2019 - 2023
- Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
5.4 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

6.1 The AI impact on Global Sexually Transmitted Diseases (STD) Treatment Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Type

8.1 Market segments
- Chart on Type - Market share 2024-2029 (%)
- Data Table on Type - Market share 2024-2029 (%)
8.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
8.3 Viral infections - Market size and forecast 2024-2029
- Chart on Viral infections - Market size and forecast 2024-2029 ($ million)
- Data Table on Viral infections - Market size and forecast 2024-2029 ($ million)
- Chart on Viral infections - Year-over-year growth 2024-2029 (%)
- Data Table on Viral infections - Year-over-year growth 2024-2029 (%)
8.4 Bacterial infections - Market size and forecast 2024-2029
- Chart on Bacterial infections - Market size and forecast 2024-2029 ($ million)
- Data Table on Bacterial infections - Market size and forecast 2024-2029 ($ million)
- Chart on Bacterial infections - Year-over-year growth 2024-2029 (%)
- Data Table on Bacterial infections - Year-over-year growth 2024-2029 (%)
8.5 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
8.6 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)

9 Market Segmentation by Route of Administration

9.1 Market segments
- Chart on Route of Administration - Market share 2024-2029 (%)
- Data Table on Route of Administration - Market share 2024-2029 (%)
9.2 Comparison by Route of Administration
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
9.3 Oral - Market size and forecast 2024-2029
- Chart on Oral - Market size and forecast 2024-2029 ($ million)
- Data Table on Oral - Market size and forecast 2024-2029 ($ million)
- Chart on Oral - Year-over-year growth 2024-2029 (%)
- Data Table on Oral - Year-over-year growth 2024-2029 (%)
9.4 Topical - Market size and forecast 2024-2029
- Chart on Topical - Market size and forecast 2024-2029 ($ million)
- Data Table on Topical - Market size and forecast 2024-2029 ($ million)
- Chart on Topical - Year-over-year growth 2024-2029 (%)
- Data Table on Topical - Year-over-year growth 2024-2029 (%)
9.5 Injectable - Market size and forecast 2024-2029
- Chart on Injectable - Market size and forecast 2024-2029 ($ million)
- Data Table on Injectable - Market size and forecast 2024-2029 ($ million)
- Chart on Injectable - Year-over-year growth 2024-2029 (%)
- Data Table on Injectable - Year-over-year growth 2024-2029 (%)
9.6 Market opportunity by Route of Administration
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)

10 Market Segmentation by End-user

10.1 Market segments
- Chart on End-user - Market share 2024-2029 (%)
- Data Table on End-user - Market share 2024-2029 (%)
10.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
10.3 Hospital and clinics - Market size and forecast 2024-2029
- Chart on Hospital and clinics - Market size and forecast 2024-2029 ($ million)
- Data Table on Hospital and clinics - Market size and forecast 2024-2029 ($ million)
- Chart on Hospital and clinics - Year-over-year growth 2024-2029 (%)
- Data Table on Hospital and clinics - Year-over-year growth 2024-2029 (%)
10.4 Diagnostic centers - Market size and forecast 2024-2029
- Chart on Diagnostic centers - Market size and forecast 2024-2029 ($ million)
- Data Table on Diagnostic centers - Market size and forecast 2024-2029 ($ million)
- Chart on Diagnostic centers - Year-over-year growth 2024-2029 (%)
- Data Table on Diagnostic centers - Year-over-year growth 2024-2029 (%)
10.5 Individuals - Market size and forecast 2024-2029
- Chart on Individuals - Market size and forecast 2024-2029 ($ million)
- Data Table on Individuals - Market size and forecast 2024-2029 ($ million)
- Chart on Individuals - Year-over-year growth 2024-2029 (%)
- Data Table on Individuals - Year-over-year growth 2024-2029 (%)
10.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
12.9 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.10 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.11 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
12.12 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
12.13 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
12.14 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ million)
- Data Table on Italy - Market size and forecast 2024-2029 ($ million)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.15 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.16 Spain - Market size and forecast 2024-2029
- Chart on Spain - Market size and forecast 2024-2029 ($ million)
- Data Table on Spain - Market size and forecast 2024-2029 ($ million)
- Chart on Spain - Year-over-year growth 2024-2029 (%)
- Data Table on Spain - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Company ranking index
- Company ranking index
15.3 Market positioning of companies
- Matrix on companies position and classification
15.4 Aurobindo Pharma Ltd.
- Aurobindo Pharma Ltd. - Overview
- Aurobindo Pharma Ltd. - Product / Service
- Aurobindo Pharma Ltd. - Key offerings
- SWOT
15.5 Becton Dickinson and Co.
- Becton Dickinson and Co. - Overview
- Becton Dickinson and Co. - Business segments
- Becton Dickinson and Co. - Key news
- Becton Dickinson and Co. - Key offerings
- Becton Dickinson and Co. - Segment focus
- SWOT
15.6 Cepheid Inc.
- Cepheid Inc. - Overview
- Cepheid Inc. - Product / Service
- Cepheid Inc. - Key offerings
- SWOT
15.7 DiaSorin SpA
- DiaSorin SpA - Overview
- DiaSorin SpA - Business segments
- DiaSorin SpA - Key news
- DiaSorin SpA - Key offerings
- DiaSorin SpA - Segment focus
- SWOT
15.8 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
15.9 Gilead Sciences Inc.
- Gilead Sciences Inc. - Overview
- Gilead Sciences Inc. - Product / Service
- Gilead Sciences Inc. - Key news
- Gilead Sciences Inc. - Key offerings
- SWOT
15.10 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
- SWOT
15.11 Hologic Inc.
- Hologic Inc. - Overview
- Hologic Inc. - Business segments
- Hologic Inc. - Key news
- Hologic Inc. - Key offerings
- Hologic Inc. - Segment focus
- SWOT
15.12 Inovio Pharmaceuticals Inc.
- Inovio Pharmaceuticals Inc. - Overview
- Inovio Pharmaceuticals Inc. - Product / Service
- Inovio Pharmaceuticals Inc. - Key news
- Inovio Pharmaceuticals Inc. - Key offerings
- SWOT
15.13 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Business segments
- Johnson and Johnson Services Inc. - Key news
- Johnson and Johnson Services Inc. - Key offerings
- Johnson and Johnson Services Inc. - Segment focus
- SWOT
15.14 Lupin Ltd.
- Lupin Ltd. - Overview
- Lupin Ltd. - Business segments
- Lupin Ltd. - Key news
- Lupin Ltd. - Key offerings
- Lupin Ltd. - Segment focus
- SWOT
15.15 Merck and Co. Inc.
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
- SWOT
15.16 Mission Pharmacal Co.
- Mission Pharmacal Co. - Overview
- Mission Pharmacal Co. - Product / Service
- Mission Pharmacal Co. - Key offerings
- SWOT
15.17 Mylan
- Mylan - Overview
- Mylan - Product / Service
- Mylan - Key offerings
- SWOT
15.18 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT

16 Appendix

16.1 Scope of the report
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations

簡介目錄圖表

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits7: Executive Summary - Chart on Market Segmentation by End-user
Exhibits8: Executive Summary - Chart on Incremental Growth
Exhibits9: Executive Summary - Data Table on Incremental Growth
Exhibits10: Executive Summary - Chart on Company Market Positioning
Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits12: Overview on criticality of inputs and factors of differentiation
Exhibits13: Overview on factors of disruption
Exhibits14: Impact of drivers and challenges in 2024 and 2029
Exhibits15: Parent Market
Exhibits16: Data Table on - Parent Market
Exhibits17: Market characteristics analysis
Exhibits18: Value chain analysis
Exhibits19: Offerings of companies included in the market definition
Exhibits20: Market segments
Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits25: Historic Market Size - Data Table on Global Sexually Transmitted Diseases (STD) Treatment Market 2019 - 2023 ($ million)
Exhibits26: Historic Market Size - Type Segment 2019 - 2023 ($ million)
Exhibits27: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
Exhibits28: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits31: Five forces analysis - Comparison between 2024 and 2029
Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits37: Chart on Market condition - Five forces 2024 and 2029
Exhibits38: Chart on Type - Market share 2024-2029 (%)
Exhibits39: Data Table on Type - Market share 2024-2029 (%)
Exhibits40: Chart on Comparison by Type
Exhibits41: Data Table on Comparison by Type
Exhibits42: Chart on Viral infections - Market size and forecast 2024-2029 ($ million)
Exhibits43: Data Table on Viral infections - Market size and forecast 2024-2029 ($ million)
Exhibits44: Chart on Viral infections - Year-over-year growth 2024-2029 (%)
Exhibits45: Data Table on Viral infections - Year-over-year growth 2024-2029 (%)
Exhibits46: Chart on Bacterial infections - Market size and forecast 2024-2029 ($ million)
Exhibits47: Data Table on Bacterial infections - Market size and forecast 2024-2029 ($ million)
Exhibits48: Chart on Bacterial infections - Year-over-year growth 2024-2029 (%)
Exhibits49: Data Table on Bacterial infections - Year-over-year growth 2024-2029 (%)
Exhibits50: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits51: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits52: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits53: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits54: Market opportunity by Type ($ million)
Exhibits55: Data Table on Market opportunity by Type ($ million)
Exhibits56: Chart on Route of Administration - Market share 2024-2029 (%)
Exhibits57: Data Table on Route of Administration - Market share 2024-2029 (%)
Exhibits58: Chart on Comparison by Route of Administration
Exhibits59: Data Table on Comparison by Route of Administration
Exhibits60: Chart on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits61: Data Table on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits62: Chart on Oral - Year-over-year growth 2024-2029 (%)
Exhibits63: Data Table on Oral - Year-over-year growth 2024-2029 (%)
Exhibits64: Chart on Topical - Market size and forecast 2024-2029 ($ million)
Exhibits65: Data Table on Topical - Market size and forecast 2024-2029 ($ million)
Exhibits66: Chart on Topical - Year-over-year growth 2024-2029 (%)
Exhibits67: Data Table on Topical - Year-over-year growth 2024-2029 (%)
Exhibits68: Chart on Injectable - Market size and forecast 2024-2029 ($ million)
Exhibits69: Data Table on Injectable - Market size and forecast 2024-2029 ($ million)
Exhibits70: Chart on Injectable - Year-over-year growth 2024-2029 (%)
Exhibits71: Data Table on Injectable - Year-over-year growth 2024-2029 (%)
Exhibits72: Market opportunity by Route of Administration ($ million)
Exhibits73: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits74: Chart on End-user - Market share 2024-2029 (%)
Exhibits75: Data Table on End-user - Market share 2024-2029 (%)
Exhibits76: Chart on Comparison by End-user
Exhibits77: Data Table on Comparison by End-user
Exhibits78: Chart on Hospital and clinics - Market size and forecast 2024-2029 ($ million)
Exhibits79: Data Table on Hospital and clinics - Market size and forecast 2024-2029 ($ million)
Exhibits80: Chart on Hospital and clinics - Year-over-year growth 2024-2029 (%)
Exhibits81: Data Table on Hospital and clinics - Year-over-year growth 2024-2029 (%)
Exhibits82: Chart on Diagnostic centers - Market size and forecast 2024-2029 ($ million)
Exhibits83: Data Table on Diagnostic centers - Market size and forecast 2024-2029 ($ million)
Exhibits84: Chart on Diagnostic centers - Year-over-year growth 2024-2029 (%)
Exhibits85: Data Table on Diagnostic centers - Year-over-year growth 2024-2029 (%)
Exhibits86: Chart on Individuals - Market size and forecast 2024-2029 ($ million)
Exhibits87: Data Table on Individuals - Market size and forecast 2024-2029 ($ million)
Exhibits88: Chart on Individuals - Year-over-year growth 2024-2029 (%)
Exhibits89: Data Table on Individuals - Year-over-year growth 2024-2029 (%)
Exhibits90: Market opportunity by End-user ($ million)
Exhibits91: Data Table on Market opportunity by End-user ($ million)
Exhibits92: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits93: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits94: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits95: Chart on Geographic comparison
Exhibits96: Data Table on Geographic comparison
Exhibits97: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits98: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits99: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits100: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits101: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits102: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits103: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits104: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits105: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits106: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits107: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits108: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits109: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits110: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits111: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits112: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits113: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits114: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits115: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits116: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits117: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits118: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits119: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits120: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits121: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits122: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits123: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits124: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits125: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits126: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits127: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits128: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits129: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits130: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits131: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits132: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits133: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits134: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits135: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits136: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits137: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits138: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits139: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits140: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits141: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits142: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits143: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits144: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits145: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits146: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits147: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits148: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits149: Chart on Spain - Market size and forecast 2024-2029 ($ million)
Exhibits150: Data Table on Spain - Market size and forecast 2024-2029 ($ million)
Exhibits151: Chart on Spain - Year-over-year growth 2024-2029 (%)
Exhibits152: Data Table on Spain - Year-over-year growth 2024-2029 (%)
Exhibits153: Market opportunity By Geographical Landscape ($ million)
Exhibits154: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits155: Impact of drivers and challenges in 2024 and 2029
Exhibits156: Overview on criticality of inputs and factors of differentiation
Exhibits157: Overview on factors of disruption
Exhibits158: Impact of key risks on business
Exhibits159: Companies covered
Exhibits160: Company ranking index
Exhibits161: Matrix on companies position and classification
Exhibits162: Aurobindo Pharma Ltd. - Overview
Exhibits163: Aurobindo Pharma Ltd. - Product / Service
Exhibits164: Aurobindo Pharma Ltd. - Key offerings
Exhibits165: SWOT
Exhibits166: Becton Dickinson and Co. - Overview
Exhibits167: Becton Dickinson and Co. - Business segments
Exhibits168: Becton Dickinson and Co. - Key news
Exhibits169: Becton Dickinson and Co. - Key offerings
Exhibits170: Becton Dickinson and Co. - Segment focus
Exhibits171: SWOT
Exhibits172: Cepheid Inc. - Overview
Exhibits173: Cepheid Inc. - Product / Service
Exhibits174: Cepheid Inc. - Key offerings
Exhibits175: SWOT
Exhibits176: DiaSorin SpA - Overview
Exhibits177: DiaSorin SpA - Business segments
Exhibits178: DiaSorin SpA - Key news
Exhibits179: DiaSorin SpA - Key offerings
Exhibits180: DiaSorin SpA - Segment focus
Exhibits181: SWOT
Exhibits182: F. Hoffmann La Roche Ltd. - Overview
Exhibits183: F. Hoffmann La Roche Ltd. - Business segments
Exhibits184: F. Hoffmann La Roche Ltd. - Key news
Exhibits185: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits186: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits187: SWOT
Exhibits188: Gilead Sciences Inc. - Overview
Exhibits189: Gilead Sciences Inc. - Product / Service
Exhibits190: Gilead Sciences Inc. - Key news
Exhibits191: Gilead Sciences Inc. - Key offerings
Exhibits192: SWOT
Exhibits193: GlaxoSmithKline Plc - Overview
Exhibits194: GlaxoSmithKline Plc - Business segments
Exhibits195: GlaxoSmithKline Plc - Key news
Exhibits196: GlaxoSmithKline Plc - Key offerings
Exhibits197: GlaxoSmithKline Plc - Segment focus
Exhibits198: SWOT
Exhibits199: Hologic Inc. - Overview
Exhibits200: Hologic Inc. - Business segments
Exhibits201: Hologic Inc. - Key news
Exhibits202: Hologic Inc. - Key offerings
Exhibits203: Hologic Inc. - Segment focus
Exhibits204: SWOT
Exhibits205: Inovio Pharmaceuticals Inc. - Overview
Exhibits206: Inovio Pharmaceuticals Inc. - Product / Service
Exhibits207: Inovio Pharmaceuticals Inc. - Key news
Exhibits208: Inovio Pharmaceuticals Inc. - Key offerings
Exhibits209: SWOT
Exhibits210: Johnson and Johnson Services Inc. - Overview
Exhibits211: Johnson and Johnson Services Inc. - Business segments
Exhibits212: Johnson and Johnson Services Inc. - Key news
Exhibits213: Johnson and Johnson Services Inc. - Key offerings
Exhibits214: Johnson and Johnson Services Inc. - Segment focus
Exhibits215: SWOT
Exhibits216: Lupin Ltd. - Overview
Exhibits217: Lupin Ltd. - Business segments
Exhibits218: Lupin Ltd. - Key news
Exhibits219: Lupin Ltd. - Key offerings
Exhibits220: Lupin Ltd. - Segment focus
Exhibits221: SWOT
Exhibits222: Merck and Co. Inc. - Overview
Exhibits223: Merck and Co. Inc. - Business segments
Exhibits224: Merck and Co. Inc. - Key news
Exhibits225: Merck and Co. Inc. - Key offerings
Exhibits226: Merck and Co. Inc. - Segment focus
Exhibits227: SWOT
Exhibits228: Mission Pharmacal Co. - Overview
Exhibits229: Mission Pharmacal Co. - Product / Service
Exhibits230: Mission Pharmacal Co. - Key offerings
Exhibits231: SWOT
Exhibits232: Mylan - Overview
Exhibits233: Mylan - Product / Service
Exhibits234: Mylan - Key offerings
Exhibits235: SWOT
Exhibits236: Thermo Fisher Scientific Inc. - Overview
Exhibits237: Thermo Fisher Scientific Inc. - Business segments
Exhibits238: Thermo Fisher Scientific Inc. - Key news
Exhibits239: Thermo Fisher Scientific Inc. - Key offerings
Exhibits240: Thermo Fisher Scientific Inc. - Segment focus
Exhibits241: SWOT
Exhibits242: Inclusions checklist
Exhibits243: Exclusions checklist
Exhibits244: Currency conversion rates for US$
Exhibits245: Research methodology
Exhibits246: Information sources
Exhibits247: Data validation
Exhibits248: Validation techniques employed for market sizing
Exhibits249: Data synthesis
Exhibits250: 360 degree market analysis
Exhibits251: List of abbreviations